Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

Sponsor
Lymphoma Study Association
Study ID
NCT00169468
Phase
PHASE2
Status
Completed

Conditions

  • B Cell Lymphoma

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The primary objective of this study is to evaluate the response rate and toxicity of the association R-CHOP with two schedules of administration of Velcade, in B-cell CD 20 + lymphoma patients, aged from 18 to 80 years The goal is to get a response rate at least at what observed with R-CHOP alone and will be evaluates with a sequential test. The other objective is to evaluate the toxicity

Key Dates

Start date
Jan 31, 2005
Status verified
Aug 2018
Primary completion
Jan 31, 2006
Completion
Jan 31, 2006

Study Design

Enrollment
48 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Rate of complete remission [ Time Frame: 1 year ]

Related Studies